Philippe Menu, the Chief Medical Officer of $SOPH, sold 5,000 shares of the company on 05-26-2026 for an estimated $24,774. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.0% of their shares of this class of stock. Following this trade, they now own 250,780 shares of this class of $SOPH stock.
$SOPH Insider Trading Activity
$SOPH insiders have traded $SOPH stock on the open market 76 times in the past 6 months. Of those trades, 0 have been purchases and 76 have been sales.
Here’s a breakdown of recent trading of $SOPH stock by insiders over the last 6 months:
- JURGI CAMBLONG (Chief Executive Officer) has made 0 purchases and 12 sales selling 100,541 shares for an estimated $492,886.
- PHILIPPE MENU (Chief Medical Officer) has made 0 purchases and 14 sales selling 36,380 shares for an estimated $174,887.
- ZHENYU XU (Chief Scientific Officer) has made 0 purchases and 12 sales selling 24,380 shares for an estimated $115,896.
- ROSS MUKEN (President) has made 0 purchases and 10 sales selling 23,393 shares for an estimated $112,590.
- WELL DAAN VAN (Chief Legal Officer) has made 0 purchases and 8 sales selling 14,406 shares for an estimated $69,282.
- MANUELA VALENTE (Chief People Officer) has made 0 purchases and 6 sales selling 9,937 shares for an estimated $48,234.
- KATHY L HIBBS sold 7,508 shares for an estimated $35,036
- GEORGE CARDOZA (Chief Financial Officer) has made 0 purchases and 4 sales selling 7,110 shares for an estimated $34,484.
- ABHIMANYU VERMA (Chief Technology Officer) has made 0 purchases and 2 sales selling 3,549 shares for an estimated $17,256.
- KEVIN PUYLAERT (Chief Sales Officer) has made 0 purchases and 7 sales selling 726 shares for an estimated $3,520.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SOPH Hedge Fund Activity
We have seen 29 institutional investors add shares of $SOPH stock to their portfolio, and 24 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 1,850,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,157,500
- KENNEDY CAPITAL MANAGEMENT LLC added 927,800 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,592,610
- ESSEX INVESTMENT MANAGEMENT CO LLC added 692,809 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,429,404
- HODGES CAPITAL MANAGEMENT INC. added 435,836 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,157,388
- ROYCE & ASSOCIATES LP added 430,257 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,009,300
- SEI INVESTMENTS CO added 357,888 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,771,545
- ENSIGN PEAK ADVISORS, INC added 262,540 shares (+143.9%) to their portfolio in Q1 2026, for an estimated $1,299,573
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SOPH Analyst Ratings
Wall Street analysts have issued reports on $SOPH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/06/2026
To track analyst ratings and price targets for $SOPH, check out Quiver Quantitative's $SOPH forecast page.
$SOPH Price Targets
Multiple analysts have issued price targets for $SOPH recently. We have seen 2 analysts offer price targets for $SOPH in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $8.0 on 05/06/2026
- Subbu Nambi from Guggenheim set a target price of $7.0 on 01/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
